Literature DB >> 8849259

Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children.

H Vinh1, J Wain, T N Vo, N N Cao, T C Mai, D Bethell, T T Nguyen, S D Tu, M D Nguyen, N J White.   

Abstract

An open randomized comparison of 2 days (Ofx2) versus 3 days (Ofx3) of oral ofloxacin treatment (15 mg/kg/day) was conducted with Vietnamese children between 1 and 15 years of age with suspected typhoid fever. Of 108 children enrolled, 100 were blood culture positive for Salmonella typhi, and 86% of the isolates were multidrug resistant. There were no significant adverse effects. The therapeutic responses were similar in both groups, with mean (+/- standard deviation) fever clearances of 107 +/- 60 h in the Ofx3 group and 100 +/- 64 h in the Ofx2 group (P > 0.2). There were six "clinical" failures in the Ofx2 group and two clinical failures in the Ofx3 group (P > 0.2), in which fever and symptoms persisted for more than 1 week after the start of treatment, but only one of these was culture positive (Ofx3). There was one suspected relapse, and one carrier was identified. Short courses of ofloxacin are simple, inexpensive, safe, and effective for the treatment of uncomplicated multidrug-resistant typhoid fever.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849259      PMCID: PMC163238     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor.

Authors:  T Butler; N N Linh; K Arnold; M Pollack
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

2.  A randomized comparative study of fleroxacin and ceftriaxone in enteric fever.

Authors:  T H Tran; M D Nguyen; D H Huynh; T T Nguyen; S D To; T P Le; K Arnold
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

3.  Multiple-drug-resistant Salmonella typhi.

Authors:  A S Mourad; M Metwally; A N el Deen; E J Threlfall; B Rowe; T Mapes; R Hedstrom; A L Bourgeois; J R Murphy
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

4.  Open study of ciprofloxacin in enteric fever.

Authors:  P J Stanley; P J Flegg; B K Mandal; A M Geddes
Journal:  J Antimicrob Chemother       Date:  1989-05       Impact factor: 5.790

5.  Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever.

Authors:  M R Wallace; A A Yousif; G A Mahroos; T Mapes; E J Threlfall; B Rowe; K C Hyams
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

6.  Treatment of typhoid fever with ofloxacin.

Authors:  F Wang; X J Gu; M F Zhang; T Y Tai
Journal:  J Antimicrob Chemother       Date:  1989-05       Impact factor: 5.790

7.  Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.

Authors:  M D Smith; N M Duong; N T Hoa; J Wain; H D Ha; T S Diep; N P Day; T T Hien; N J White
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

8.  Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever.

Authors:  A K Uwaydah; H al Soub; I Matar
Journal:  J Antimicrob Chemother       Date:  1992-11       Impact factor: 5.790

9.  Emergence of multidrug-resistant Salmonella typhi in rural southern India.

Authors:  P S Rao; V Rajashekar; G K Varghese; P G Shivananda
Journal:  Am J Trop Med Hyg       Date:  1993-01       Impact factor: 2.345

10.  Ciprofloxacin for treatment of severe typhoid fever in children.

Authors:  P Dutta; R Rasaily; M R Saha; U Mitra; S K Bhattacharya; M K Bhattacharya; M Lahiri
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  18 in total

1.  Serology of typhoid fever in an area of endemicity and its relevance to diagnosis.

Authors:  D House; J Wain; V A Ho; T S Diep; N T Chinh; P V Bay; H Vinh; M Duc; C M Parry; G Dougan; N J White; T T Hien; J J Farrar
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.

Authors:  J Y Wang; M F Pasetti; F R Noriega; R J Anderson; S S Wasserman; J E Galen; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.

Authors:  D B Bethell; N P Day; N M Dung; C McMullin; H T Loan; D T Tam; L T Minh; N T Linh; N Q Dung; H Vinh; A P MacGowan; L O White; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 4.  Quinolones in the treatment of typhoid fever.

Authors:  H E Akalin
Journal:  Drugs       Date:  1999       Impact factor: 9.546

5.  Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.

Authors:  Christopher M Parry; Chau Tran Thuy; Sabina Dongol; Abhilasha Karkey; Ha Vinh; Nguyen Tran Chinh; Pham Thanh Duy; Tran Vu Thieu Nga; James I Campbell; Nguyen Van Minh Hoang; Amit Arjyal; Zulfiqar A Bhutta; Sujit K Bhattacharya; Magdarina D Agtini; Baiqing Dong; Do Gia Canh; Aliya Naheed; John Wain; Tran Tinh Hien; Buddha Basnyat; Leon Ochiai; John Clemens; Jeremy J Farrar; Christiane Dolecek; Stephen Baker
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

6.  Mechanism of therapeutic effectiveness of cefixime against typhoid fever.

Authors:  Y Matsumoto; A Ikemoto; Y Wakai; F Ikeda; S Tawara; K Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 7.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

8.  Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial.

Authors:  S Unal; M Hayran; S Tuncer; D Gür; O Uzun; M Akova; H E Akalin
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

9.  Endemic, epidemic clone of Salmonella enterica serovar typhi harboring a single multidrug-resistant plasmid in Vietnam between 1995 and 2002.

Authors:  Thi Anh Hong Le; Monique Lejay-Collin; Patrick A D Grimont; Thuy Long Hoang; Thi Vinh Nguyen; Francine Grimont; Maurice R Scavizzi
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 10.  Current trends in typhoid Fever.

Authors:  Nancy F Crum
Journal:  Curr Gastroenterol Rep       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.